Tag: PCR London Valves 2025
AltaValve early feasibility study reports out to one year
One-year outcomes from the early feasibility study (EFS) assessing AltaValve System (4C Medical ...
“Durable” valve performance seen with early generation transapical TMVR system
Five-year results of the pilot study of the early-generation Intrepid (Medtronic) transcatheter ...
Largest dataset from ALIGN-AR trial shows favourable outcomes with Trilogy valve
Data from 700 patients treated for severe aortic regurgitation (AR) with the Trilogy (Jenavalve)...
Latest data from Dragonfly pivotal studies shared at PCR London Valves
Latest clinical data for the Dragonfly transcatheter mitral valve repair (TMVR) system (Valgen M...
Vascular complications uncommon in study of latest-generation arterial closure device
No major vascular complications were seen in the ELITE trial using the latest-generation PerQsea...
Philips previews AI-powered guidance system for mitral TEER procedures
Royal Philips has introduced DeviceGuide, an artificial intelligence (AI)-powered device trackin...
PCR London Valves 2025 hears latest data from LANDMARK trial of Myval TAVI device
Meril Life Sciences has announced the release of one-year outcomes from the pivotal LANDMARK ran...
Cost analysis suggests benefit of early TAVI in asymptomatic aortic stenosis
Edwards Lifesciences has announced the results of a health economics study across nine European ...
Low rates of PPM seen following TAVI in small aortic annuli with DurAVR system
Thirty-day clinical outcomes for the DurAVR (Anteris Technologies) transcatheter heart valve (TH...
TARGET study demonstrates TR reduction with Cardiovalve system
Venus Medtech has announced the submission of technical files for CE mark approval of the Cardio...
Report seeks to level the playing field for women in heart valve care
For Jacqueline Lewis, a former nurse and pharmaceutical industry executive, the path to heart valve ...
